Mujollari J, Estruch M, Khadgawat P, Choudhary S, et al. The glycosaminoglycan oncofetal chondroitin sulfate is a novel target for antibody-drug conjugate therapy for AML. Blood 2026;147:1229-1236.
PMID: 41405498